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We previously described a genetically unstable human
¢broblast cell strain (GM2995), isolated from normal
appearing skin of a xeroderma pigmentosum group C
patient that repeatedly underwent changes characteris-
tic of the transformed phenotype upon serial cultiva-
tion in vitro. In order to gain information concerning
genetic changes associated with the transformation of
this xeroderma pigmentosum group C cell strain, we
examined the expression/function of several cell cycle
regulators during its serial cultivation. A mutation in
exon 8 of the P53 gene was associated with loss of func-
tion of the p53 protein and appeared at about the same
time that transformation occurred. Abnormal P53 func-
tion was con¢rmed by the lack of upregulation of p53 as
well as activation of its downstream e¡ectors p21Waf1
and HDM2 in high passage cells exposed to either c
irradiation or ultraviolet C irradiation. Consistent with
deregulation in cell cycle control, persistent hyper-
phosphorylation of the retinoblastoma protein and lack
of a decrease in p34cdc2 were observed in irradiated cells.
Furthermore, retinoblastoma protein remained hyper-
phosphorylated in control high passage con£uent cul-
tures that were serum starved for 72 h. Compared with
low passage cells, the expression levels of the cyclin-
dependent kinase inhibitor p27Kip1were signi¢cantly re-
duced and the pattern of expression of the von Hippel-
Lindau protein was aberrant. These data indicate that
the process of cellular transformation of this xeroderma
pigmentosum group C cell strain involves the progres-
sive acquisition of mutations and abnormalities in the
expression/function of several cell cycle regulators.
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S
pontaneous immortalization and transformation of nor-
mal human diploid ¢broblasts in vitro is a very rare oc-
currence (Thielmann et al, 1983; Mukherji et al, 1984),
presumably involving several mutational events. Im-
mortalization of human cells has been induced by
transfection with certain oncogenes or viral genes, such as SV40
(Daya-Grosjean et al, 1987) or human papillomavirus E6 and E7
(Tsang et al, 1995) whose products inactivates the p53 and retino-
blastoma proteins (pRb). Transfection of near senescent human
diploid ¢broblasts with a retroviral construct encoding a domi-
nant-negative mutant of p53 has been reported to extend their
proliferative life span (Bond et al, 1994), and the life span of nor-
mal human ¢broblasts was also extended by an anti-sense oligo-
mer against RB-1 (Hara et al, 1991). On the other hand, normal
human ¢broblasts transfected with either the RAS oncogene or
mutant P53 were neither immortalized nor transformed (Namba
et al, 1993).
Previous attempts to immortalize xeroderma pigmentosum
(XP) ¢broblasts with constructs coding for SV40 large T antigen
were successful (frequency of approximately 5108) in comple-
mentation groups B, C, and G (Daya-Grosjean et al, 1987; Klein et
al, 1990) and was extremely rare in the XP variant even when cells
were cotransfected with human papilloma virus 16 or treated
with ionizing radiation (Volpe and Cleaver, 1995). In one case
where SV40 transfection resulted in immortalization of group C
cells (Naiman and Canaani, 1989), it was thought that the immor-
tal lines arose through selection of a peculiar karyotype from
among those of the parent SV40-transformed ¢broblasts.
We previously reported that a diploid ¢broblast cell strain
(GM2995) derived from normal-appearing skin of an XPC
patient repeatedly underwent changes characteristic of the
transformed phenotype upon serial cultivation in vitro. These in-
cluded morphologic changes, aneuploidy, prolonged lifespan, and
the ability to grow under anchorage-independent conditions in
soft agar (Nagasawa et al, 1987). As defects in cell cycle progression
pathways and in associated checkpoints have been proposed to
contribute to the process of carcinogenesis (Bartkova et al, 1997),
we examined the function of several genes involved in these
pathways.We show that the development of the transformed phe-
notype in these XPC cells correlated with the loss of function of
p53, a key cell cycle regulator, and in loss of the cellular ability
to transactivate its target genes (e.g., p21Waf1 and HDM2) upon
exposure to DNA damaging agents. Abnormalities in the expres-
sion of other cell cycle regulators are also reported.
MATERIALS ANDMETHODS
Human skin ¢broblast cell strains were obtained from the human mutant
cell repository at the Coriell Institute for Medical Research (Camden, NJ).
The proband XPC strain GM2995 was derived from a 10 y old male patient
and GM2996 from a 7 mo old a¡ected male sibling. Normal strain AG1521
Reprint requests to: John B. Little, MD, Department of Cancer Cell
Biology, Harvard School of Public Health, 665 Huntington Avenue,
Boston, MA 02115, U.S.A. Email: jlittle@hsph.harvard.edu
Abbreviation: XPC, xeroderma pigmentosum group C; AT, ataxia telan-
giectasia.
Manuscript received June 13, 2002; revised August 9, 2002; accepted for
publication August 26, 2002
0022-202X/02/$15.00  Copyrightr 2002 by The Society for Investigative Dermatology, Inc.
1350
was derived from the foreskin of a 3 d old male. These cell strains were
received at passage 3 or 4. Cells were cultured in Eagle’s minimal essential
medium supplemented with 10% heat-inactivated fetal bovine serum
(FBS), 50 U penicillin per ml, and 50 mg streptomycin per ml. They were
routinely subcultured at a 1 : 4 dilution. All experiments were carried out
with con£uent cultures. For experiments, the diluted cells were refed on
days 5 and 7, by which time they were con£uent. They were then refed
with Eagle’s minimal essential medium containing 0.1% FBS. After 24 h,
they were refed again with Eagle’s minimal essential medium with 0.1%
FBS. g-irradiation with 5.4 Gy, a dose that reduces clonogenic survival of
AG1521 ¢broblasts to about 5% (Azzam et al, 2000) was carried out 48 h
after the last feeding with a Cobalt-60 g-ray unit yielding a dose rate of
0.12 Gy per second. Ultraviolet (UV) light (254 nm) irradiation with 5 J
per m2, a dose that reduces survival of GM2995 cells to about 0.1%, was
derived from a specially constructed source (Chan and Little, 1981).
Following irradiation, con£uent cultures were held at 371C for various
time periods prior to harvesting for protein analysis by standard western
blotting techniques (Azzam et al, 1997). Brie£y, following harvesting by
trypsinization, the cells were pelleted, rinsed in phosphate-bu¡ered saline,
repelleted, and lyzed in chilled RIPA bu¡er (50 mM Tris^Cl, pH 7.5/150
mM NaCl/1% Nonidet P-40/0.5% sodium deoxycholate/0.1% sodium
dodecyl sulfate). The RIPA bu¡er was supplemented with the following
protease and phosphatase inhibitors: phenylmethylsulfonyl £uoride
(1 mM), aprotinin (1 mg per ml), pepstatin (1 mg per ml), leupeptin (1 mg
per ml), sodium £uoride (50 mM), and sodium orthovanadate (1 mM).
Anti-p53 (Ab-6), anti-p21Waf1 (Ab-1), anti-pRb (Ab-6), and anti-VHL
(Ab-1) were obtained from Oncogene Research Products (Oncogene,
Bostan, MA); anti-p34cdc2 (Sc-54), anti-HDM2 (SMP14) and anti-p16ink4
(C-20) were from Santa Cruz Biotechnology (Santa Cruz Biotechnology,
Santa Cruz, CA); anti-p27Kip1 (K25020) was obtained from Transduction
Laboratories (Transduction Laboratories, San Diego, CA). Anti-a-tubulin
(Ab-1) from Oncogene Research Products was used to verify whether the
samples were equally loaded. An anti-mouse IgG second antibody conju-
gated with horseradish peroxidase and the enhanced chemiluminescence
system from New England Nuclear (NEW Life Sciences Products, Inc.,
Bostan, MA) were used to detect the various proteins.
Single-strand conformational polymorphism analysis was carried out as
previously described (Li et al, 1994). Oligonucleotide primers speci¢c for
each of exons 6^9 of P53 were used to generate polymerase chain reaction
fragments from genomic DNA.
RESULTS AND DISCUSSION
Abnormal expression/regulation of ATM, p53, p21Waf1,
HDM2, and p34cdc2 in high passage GM2995 cells To
investigate the molecular events associated with the
transformation of GM2995 ¢broblasts, the expression patterns of
p53, p21Waf1, HDM2, and p34cdc2 proteins from early,
intermediate, and advanced passages were examined at various
time intervals after g-irradiation with 5.4 Gy (Fig 1). AG1521
normal human ¢broblasts at passage 11 were also examined for
comparison. As can be seen in Fig 1 (panel A), p53 was strongly
induced in passage 9 cells by 3 h after irradiation and remained
induced up to 48 h. A weaker induction occurred by 3 h in
passage 15 cells. Overexpression of p53 but no evidence of
induction by radiation was seen by passage 27 (Fig 1, panel B)
for up to 48 h after exposure. The p53 downstream e¡ector
p21Waf1 was induced by radiation in passage 9 cells but not in
passage 15 or 27 cells, suggesting that by passage 15 the trans-
activating function of p53 had become abnormal in the majority
of cells. Results (not shown) indicated that the modulation of
expression of HDM2, which is also a p53-responsive gene, was
like p21Waf1 rapidly induced in low passage-irradiated GM2995
cells. In contrast, its expression was not enhanced by 48 h after
g-irradiation of high passage cells, although constitutive
expression of p53 was observed at all time intervals studied
(Fig 1, panel B).
Downregulation of p34cdc2 in irradiated normal human diploid
¢broblasts was previously shown to occur in a p53-dependent
manner (Azzam et al, 1997; de Toledo et al, 1998). To con¢rm
further that p53 function is lost in high passage GM2995 cells, the
expression of p34cdc2 was examined in irradiated cells at passage 22
and in their respective sham-treated controls (Fig 1, panel C).
Whereas p34cdc2 was downregulated by 24 h after irradiation in
normal human AG1521 cells, its levels were unaltered in the
GM2995 cells further supporting the development of an
abnormal p53 function in these XPC cells that leads to abnormal
regulation of cell cycle-regulated genes. Similar to the results with
GM2995 cells, a lack of downregulation of p34cdc2 was previously
observed in irradiated, genomically unstable, ataxia telangiectasia
(AT) cells (de Toledo et al, 1998).
To con¢rm that loss of function of p53 is not a general
phenomenon that normally occurs in high passage human
¢broblasts, p53 expression/function was examined in a control
¢broblast strain (GM2996) at low, intermediate, and high
passages. GM2996 cells were derived from a 7 mo old a¡ected
sibling of GM2995. GM2996 cultures were carried for up to 36
passages and showed no morphologic changes or other evidence
of transformation. Normal expression of p53 was observed up to
passage 36 (Fig 2). Its functional integrity was supported by its
increased expression levels and ability to trans-activate p21Waf1 in
g-irradiated cells.
Several studies have indicated that ATM is involved in the
speci¢c signaling pathway induced by DNA double-strand breaks
that result from exposure to ionizing radiation (Kastan
et al, 1992; Lavin and Khanna, 1999). Compared with normal cells,
p53 accumulation in AT cells exposed to ionizing radiation is
signi¢cantly delayed and reduced, although it appears to be
normal in UV-irradiated AT cells. To investigate whether the lack
of p53 activation by g-rays in high passage GM2995 cells was
related to loss of function of ATM in these cells, expression of
p53 and p21Waf1 was examined following exposure to UV light
radiation (UVC, 254 nm). The data in Fig 3 show p53 and
p21Waf1 expression in control and UVC-irradiated GM2995 cells
at passages 9, 15, and 28. The results are similar to those for g-
irradiation (Fig 1); weak induction of p53 but no induction of
p21Waf1 was observed at passage 15. Consistent overexpression of
p53 independent of UVC exposure occurred in passage 28 cells.
These data therefore indicate that p53 activation by UVC
irradiation is compromised at high passage GM2995 cells and
suggest the existence of either a defective ATM or p53 gene in
these cells.
Figure1. Expression of p53, p21Waf1, HDM2, and p34cdc2 3^48 h
postirradiation in control (C) and c-irradiated (5.4 Gy) GM2995
¢broblasts at various culture passages. AG1521 is a normal control
¢broblast strain (p¼passage number).
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ATM expression in GM2995 cells was analyzed by western
blotting. Data (not shown) indicated expression of the expected
high molecular weight (350 kDa) ATM protein in low and high
passage cells. In addition, we observed expression of a slow-
migrating 100^120 kDa protein that reacts with the anti-ATM
antibody (Fig 4). Whereas a predominant single band was
detected in low passage GM2995 cells (passages 7 and 15), as well
as in AG1521 and ¢broblasts derived from three Li^Fraumeni
patients, two bands were observed consistently in high passage
GM2995 cells (passage 22, Fig 4). Whether the slower migrating
protein in high passage cells is a distinct protein or rather a
modi¢ed form (e.g., phosphorylated) of the protein expressed in
low passage GM2995 cells as well as the other cell strains
examined remains to be determined.
Loss of p53 function in high passage GM2995 cells is due to
mutation and is associated with the loss of cellular contact
inhibition. Single-strand conformational polymorphism
analysis of the P53 gene in early to late passage GM2995 cells is
shown in Fig 5. As can be seen, evidence for mutation in exon 8
occurred by passage 17. In one experiment, evidence for late
passage mutation was also found in exon 6 (data not shown).
The above ¢ndings (Figs 1, 3^5) correlate with the observation
that morphologic transformation occurred in GM2995 cells
by passage 13, whereas a high frequency of cells grew under
anchorage-independent conditions in soft agar by passage 20
(Fig 6). In ¢ve separate experiments, passage 5 cells were
cloned and serially cultivated. In all cases, high passage cells
showed morphologic transformation, exhibited increasing
anchorage independence, and formed round, smooth-edged
colonies in soft agar. These results suggest that transformation is
associated with genetic instability in this XP cell strain. It is this
instability that would lead to the development of p53 mutations,
rather than the occurrence of a small number of cells carrying a
pre-existing p53 mutation in the original cell strain that
subsequently gained a selective growth advantage during
cultivation in vitro.
Abnormal expression of p27Kip1, pRb, and VHL
proteins. Loss of the G1 checkpoint has been associated with
the process of cellular transformation (Syljuasen et al, 1999). In
addition to the above analyses (Figs 1^5) of ATM, p53, and
p21Waf1, which are key regulators of this checkpoint, expression
of the cyclin-cdk inhibitors p16ink4 and p27kip1 in GM2995 cells
was also examined by western analysis in high and low passage
cells at various times after irradiation (Fig 7). As can be seen,
p16ink4, an inhibitor of cyclin D/cdk4 and whose loss is common
in many cancers (Sherr, 2000; Malumbres and Barbacid, 2001),
was expressed at about the same level in nonirradiated and
irradiated cells from both early and late passage cultures. The
levels of p27kip1 protein, on the other hand, are barely detectable
in the higher passage cells. They were unaltered following
Figure 2. p53 and p21Waf1 expression 3^48 h postirradiation in con-
trol (C) and c-irradiated (5.4 Gy) GM2996 cells at di¡erent culture
passages (p¼passage number).
Figure 3. p53 and p21Waf1 expression in control (C) and UVC-irra-
diated (V) GM2995 cells. (A) Expression 3 h after irradiation of cells at
passage levels 9, 15, and 28. (B) Expression in cells at passage 9 and 28
examined 3, 6, or 48 h after irradiation.
Figure 4. ATM expression in various cell strains 3 h after exposure to
c-irradiation. T2, B9, and 1264 are skin ¢broblast cell strains isolated from
patients with the Li^Fraumeni syndrome. Shown is a slowly migrating pro-
tein of molecular weight 100^120 kDa that reacts with the anti-ATM anti-
body. The second (upper) band was seen consistently in high passage
GM2995 cells. The high molecular weight ATM protein (350 kDa)
observed in all cells at all passage levels is not shown.
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exposure to ionizing radiation at either passage level.The removal
of p27Kip1, an inhibitor of cyclin D/cdk4 and of cyclin E/cdk2,
was previously shown to be required for cellular progression
into S-phase (reviewed in Kato, 1999). Hence its aberrant
expression as well as that of p53 and p21Waf1 point to defective
function of several G1 phase regulators in high passage GM2995
cells. The cause of the downregulation of p27Kip1 in these cells is
unknown. Whereas p21Waf1 is regulated at the transcriptional
level, however, the abundance of p27Kip1 within the cell is
mainly regulated at the translational level (Sherr and Roberts,
1995) and degradation (Pagano et al, 1995) level. It is of interest
to note that reduced expression of p27Kip1 has been reported to
correlate with the short survival time of cancer patients (Loda et
al, 1997; Porter et al, 1997).
The existence of a defective G1 checkpoint in high passage
GM2995 cells is further supported by the pattern of pRb
expression in control and irradiated cells. Although con£uent
GM2995 cells were cultured in medium supplemented with
0.1% FBS for 72 h, a persistent hyperphosphorylation of pRb
was observed in nonirradiated passage 15 cells (Fig 8). This
hyperphosphorylation was maintained for 24 h after exposure to
5.4 Gy. Such persistent hyperphosphorylation of pRb was not
observed in passage 7 cells (Fig 8).
It has been shown previously that the product of the von
Hippel-Lindau (VHL) gene plays an important part in regulating
cell cycle exit by serum deprivation (Pause et al, 1998). Thus, we
investigated the expression of VHL by western analysis in control
and UVC-irradiated GM2995 cells at passage 9 and passage 28.
Whereas the data in Fig 9 indicate expression of the expected
30 kDaVHL protein in passage 9 cells, passage 28 cells exhibited
expression of an additional protein of 37 kDa that reacts with the
anti-VHL antibody. Expression of such an additional protein that
is immunoreactive to anti-VHL in high passage cells correlates
with lack of accumulation of p27Kip1 in serum-starved cells (Fig
7) and the inability to exit the cell cycle as demonstrated by the
persistent phosphorylation of pRb (Fig 8) and lack of activation
of p53/p21Waf1 upon irradiation (Figs 1 and 3).
We conclude that the process of transformation of this XPC
cell strain (GM2995) is associated with altered expression/
function of several gene products that participate in several
Figure 5. Single-strand conformational polymorphism analysis of
exons 6^9 of the P53gene in GM 2995 (XPC5) cells at passages 8, 17,
and 28, indicating a mutation in exon 8 had occurred by passage 17.
AG1521 is a normal control cell strain.
Figure 6. (I) Cell morphology of colonies of GM2995 cells in mono-
layer culture after seeding single cells at low density. (A) GM2995
(passage 6); (B) GM2995 (passage 13); (C) GM2995 (passage 13) (dense col-
ony). The cultures were ¢xed with methanol and stained with Giemsa for
10 min.(II) Appearance of colonies in soft agar. (A) GM2995 (passage 6);
(B) GM2995 (passage 14); (C) GM2995 (passage 31). Bars¼ 0.1 mm.
Figure 7. p16ink4and p27Kip1 expression in control (C) and c-irra-
diated (5.4 Gy) GM2995 cells examined at passages 9 and 15. Expres-
sion levels at 3.5, 26, and 48 h after irradiation are shown.
Figure 8. Phosphorylation of pRb in control and c-irradiated
GM2995 cells examined 2^24 h postirradiation in cells at passage 7
or 15.
Figure 9. VHL expression in control (C) and UVC-irradiated (V)
GM2995 cells examined at passages 9 or 28.
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signaling pathways leading to cell cycle regulation. The exact
chronologic order of occurrence of the above changes and the
correlation with the onset of transformation requires further
investigation. Mutations in p53 may a¡ect its post-translational
modi¢cations, biochemical activities, and interactions with other
proteins (Jimenez et al, 1999). The mutations may alter the
conformation of p53 and render speci¢c targets in the protein
(proximal and distal to the mutation) less accessible or
unsuitable to kinase/phosphatase activities that occur due to
normal cellular metabolism or in response to stress. Alterations
in the sequence of p53 may also a¡ect its interactions with
HDM2 and hence its stability (Freedman and Levine, 1999). The
data in Figs 1 and 3 indicate that at least the p53 ability to trans-
activate p21Waf1 and HDM2 is compromised with the
development of a mutation in exon 8.Whereas it is of interest to
test whether restoration of normal p53 function in late passage
cells would prevent the expression of transformed traits in these
cells, the inherent genomic instability in these XPC cells is likely
to abrogate the function of the restored p53 protein with cellular
passaging.
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